Site Search

... Bill 989 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.     “ACS CAN thanks Sen. Joan Huffman and Rep. Greg Bonnen for their leadership on biomarker testing legislation and Gov. Abbott for signing this important piece of legislation,” said James Gray, Texas government relations director for the American Cancer Society Cancer Action Network (ACS CAN). “This legislation will help dismantle barriers and bring the promise of precision medicine to more cancer patients. This can provide many benefits to patients, including better outcomes, improved quality of life, and ...